Clinical Trials Browser

INDUSTRY × Crizotinib × Tumor-Agnostic × Clear all

NCT02473497 2024-06-26

Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients

No longer available

Neoplasms

NCT01999972 2020-09-24

A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors

Phase 1 Completed

50 enrolled 29 charts

Carcinoma